Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216) https://t.co/Wa4kXHGi8M

RT @uscnorris: In a phase III trial for men with prostate cancer, Dr. Goldkorn and colleagues identified the very first blood-based biomark…

RT @uscnorris: In a phase III trial for men with prostate cancer, Dr. Goldkorn and colleagues identified the very first blood-based biomark…

RT @uscnorris: In a phase III trial for men with prostate cancer, Dr. Goldkorn and colleagues identified the very first blood-based biomark…

In a phase III trial for men with prostate cancer, Dr. Goldkorn and colleagues identified the very first blood-based biomarker that predicts the success of hormonal therapy for prostate cancer and lays the foundation for its use in the clinic. Link below.

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

@OncoAlert

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @NatRevUrol: Baseline CTC level in SWOG S1216 study of mCSPC is highly prognostic of 7-month PSA and 2-year PFS after adjusting for dise…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216) https://t.co/WecKccA5wV

Baseline CTC level in SWOG S1216 study of mCSPC is highly prognostic of 7-month PSA and 2-year PFS after adjusting for disease burden and discriminates men who are likely to experience poor survival outcomes, according to a @CCR_AACR study https://t.co/wFr

RT @shilpaonc: Huge congrats @neerajaiims @Huntsman_GU and team on leading this novel correlative work prospectively evaluating the role of…

RT @cdanicas: Impressive result of #prostate cancer SWOG team about baseline CTCs and survival for mCSPC pts! 👉 is it time to also incorpor…

RT @cdanicas: Impressive result of #prostate cancer SWOG team about baseline CTCs and survival for mCSPC pts! 👉 is it time to also incorpor…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @montypal: Enjoyed spending time w @neerajaiims at my 1st @SWOG mtg & every mtg since (below: our matching @SupportingSWOG ties). His pa…

RT @shilpaonc: Huge congrats @neerajaiims @Huntsman_GU and team on leading this novel correlative work prospectively evaluating the role of…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @montypal: Enjoyed spending time w @neerajaiims at my 1st @SWOG mtg & every mtg since (below: our matching @SupportingSWOG ties). His pa…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @montypal: Enjoyed spending time w @neerajaiims at my 1st @SWOG mtg & every mtg since (below: our matching @SupportingSWOG ties). His pa…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @montypal: Enjoyed spending time w @neerajaiims at my 1st @SWOG mtg & every mtg since (below: our matching @SupportingSWOG ties). His pa…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @chadinabhan: Very important work by @neerajaiims and team; important findings and agree with considering trials in this subset. More co…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @montypal: Enjoyed spending time w @neerajaiims at my 1st @SWOG mtg & every mtg since (below: our matching @SupportingSWOG ties). His pa…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @montypal: Enjoyed spending time w @neerajaiims at my 1st @SWOG mtg & every mtg since (below: our matching @SupportingSWOG ties). His pa…

RT @cdanicas: Impressive result of #prostate cancer SWOG team about baseline CTCs and survival for mCSPC pts! 👉 is it time to also incorpor…

RT @cdanicas: Impressive result of #prostate cancer SWOG team about baseline CTCs and survival for mCSPC pts! 👉 is it time to also incorpor…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @shilpaonc: Huge congrats @neerajaiims @Huntsman_GU and team on leading this novel correlative work prospectively evaluating the role of…

RT @montypal: Enjoyed spending time w @neerajaiims at my 1st @SWOG mtg & every mtg since (below: our matching @SupportingSWOG ties). His pa…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

Enjoyed spending time w @neerajaiims at my 1st @SWOG mtg & every mtg since (below: our matching @SupportingSWOG ties). His passion for #clinicaltrials was (and is) unparralleled & his commitment to #S1216 beyond compare. Great to see impt biomarker

RT @shilpaonc: Huge congrats @neerajaiims @Huntsman_GU and team on leading this novel correlative work prospectively evaluating the role of…

Very important work by @neerajaiims and team; important findings and agree with considering trials in this subset. More complex question is what agents and the end points? Kudos to a great effort. CC @matthewoberley

RT @cdanicas: Impressive result of #prostate cancer SWOG team about baseline CTCs and survival for mCSPC pts! 👉 is it time to also incorpor…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

Working with @neerajaiims is great—inspires me daily! Interested to see what else we learn from these poor prognosis patients so better treatments are developed in the future. Biology should drive treatment, not necessarily anatomy. Slowly getting there!

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @shilpaonc: Huge congrats @neerajaiims @Huntsman_GU and team on leading this novel correlative work prospectively evaluating the role of…

RT @shilpaonc: Huge congrats @neerajaiims @Huntsman_GU and team on leading this novel correlative work prospectively evaluating the role of…

RT @shilpaonc: Huge congrats @neerajaiims @Huntsman_GU and team on leading this novel correlative work prospectively evaluating the role of…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

Huge congrats @neerajaiims @Huntsman_GU and team on leading this novel correlative work prospectively evaluating the role of CTCs in important trial in met hormone sensitive #prostatecancer @SWOG @PrimoLaraMD @PCF_Science

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @Huntsman_GU: Congratulations to our faculty @Neerajaiims for leading this @theNCI funded @SWOG S1216 study published in @CCR_AACR today…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @cdanicas: Impressive result of #prostate cancer SWOG team about baseline CTCs and survival for mCSPC pts! 👉 is it time to also incorpor…

RT @Huntsman_GU: Congratulations to our faculty @Neerajaiims for leading this @theNCI funded @SWOG S1216 study published in @CCR_AACR today…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

Thanks @neerajaiims & team for a really important study! @NeliMUlrich @maughanonc @umangtalking @Huntsman_GU

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @Huntsman_GU: Congratulations to our faculty @Neerajaiims for leading this @theNCI funded @SWOG S1216 study published in @CCR_AACR today…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @Huntsman_GU: Congratulations to our faculty @Neerajaiims for leading this @theNCI funded @SWOG S1216 study published in @CCR_AACR today…

RT @cdanicas: Impressive result of #prostate cancer SWOG team about baseline CTCs and survival for mCSPC pts! 👉 is it time to also incorpor…

Impressive result of #prostate cancer SWOG team about baseline CTCs and survival for mCSPC pts! 👉 is it time to also incorporate ctDNA? @Silke_Gillessen @ChrisSweens1 @AttardLab @EAntonarakis @Prof_Nick_James @montypal @PGrivasMDPhD

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @Huntsman_GU: Congratulations to our faculty @Neerajaiims for leading this @theNCI funded @SWOG S1216 study published in @CCR_AACR today…

RT @TiansterZhang: Important CTC biomarker work from @neerajaiims @Huntsman_GU @SWOG for prognostic value of CTCs in metastatic hormone sen…

RT @Huntsman_GU: Congratulations to our faculty @Neerajaiims for leading this @theNCI funded @SWOG S1216 study published in @CCR_AACR today…

RT @Huntsman_GU: Congratulations to our faculty @Neerajaiims for leading this @theNCI funded @SWOG S1216 study published in @CCR_AACR today…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @TiansterZhang: Important CTC biomarker work from @neerajaiims @Huntsman_GU @SWOG for prognostic value of CTCs in metastatic hormone sen…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @Huntsman_GU: Congratulations to our faculty @Neerajaiims for leading this @theNCI funded @SWOG S1216 study published in @CCR_AACR today…

RT @TiansterZhang: Important CTC biomarker work from @neerajaiims @Huntsman_GU @SWOG for prognostic value of CTCs in metastatic hormone sen…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

Important CTC biomarker work from @neerajaiims @Huntsman_GU @SWOG for prognostic value of CTCs in metastatic hormone sensitive #prostatecancer. @Daniel_J_George @AarmstrongDuke

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…

RT @Huntsman_GU: Congratulations to our faculty @Neerajaiims for leading this @theNCI funded @SWOG S1216 study published in @CCR_AACR today…

RT @neerajaiims: Our study in @CCR_AACR today: 1st report from a federally funded prospective trial (@SWOG S1216) in new metastatic #prosta…